{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:24:13Z","timestamp":1781760253034,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the surgical treatment approaches for patients with Cesarean scar pregnancy (CSP) and the effects on subsequent pregnancy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>CSP patients admitted to Shengjing Hospital of China Medical University from January 2013 to December 2018 were retrospectively analyzed to collect their clinical characteristics, and follow-up of postoperative pregnancies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1126 CSP patients were enrolled in this study, including 595 (52.84%) CSP type I, 415 (36.86%) CSP type II, and 116 (10.30%) CSP type III cases. There were significant differences between the three types of patients in terms of \u03b2-HCG levels, gestational sac diameter, clinical symptoms and presence of fetal heartbeat at diagnosis (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). Among these, 89.90% of CSP type I, 88.90% of CSP type II and 50% of CSP type III\u00a0patients were treated with hysteroscopic lesion excision, 7.9% of CSP type I and 2.2% of CSP type II patients underwent ultrasound-monitored curettage, and the remaining patients underwent lesion excision and and simultaneous repair of excised lesions by different routes (trans-laparoscopic, transabdominal or transvaginal methods). And 5.55% of CSP type I, 22.65% of CSP type II and 43.10% of CSP type III patients were treated with adjunctive uterine artery embolization (UAE). The patients were followed up for more than 2\u00a0years after surgery. Among the 166 re-pregnancies, 58 (34.94%) were normal pregnancies, 17 patients reoccurred with CSP, the recurrent rate of CSP was 10.24%. All 58 normal pregnancies were terminated by cesarean section, with a mean gestational week of delivery of (38.36\u2009\u00b1\u20092.25) weeks, a mean birth weight of (3228.45\u2009\u00b1\u2009301.96)g, and the postnatal Apgar score was (9.86\u2009\u00b1\u20090.23) points at 1\u00a0min and all 5\u00a0min were 10 points. Logistic regression analysis suggested that the number of previous cesarean deliveries was a risk factor for recurrent CSP (RCSP) (OR\u2009=\u200910.82, 95% CI: 2.52\u201346.50, <jats:italic>P<\/jats:italic>\u2009=\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The type of CSP is related to \u03b2-HCG values, presence of fetal heartbeat, gestational sac diameter and clinical symptoms. Hysteroscopic therapy is a commonly used surgical procedure and UAE is often used as an adjuvant treatment. For subsequent pregnancies, the number of previous cesarean deliveries is a risk factor for recurrent CSP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-04965-9","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T10:03:04Z","timestamp":1660644184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Analysis of pregnancy outcomes following surgical treatment of cesarean scar pregnancy"],"prefix":"10.1186","volume":"22","author":[{"given":"Zongxu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"4965_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1471-0528.2006.01237.x","volume":"114","author":"A Ash","year":"2007","unstructured":"Ash A, Smith A, Maxwell D. Caesarean scar pregnancy. BJOG. 2007;114:253\u201363.","journal-title":"BJOG"},{"key":"4965_CR2","first-page":"926","volume":"36","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhang Y-Q, He J, Zhang L. Outcomes of subsequent pregnancies in patients following treatment of cesarean scar pregnancy with high intensity focused ultrasound followed by ultrasound-guided dilation and curettage. Int J Hyperthermia. 2019;36:926\u201331.","journal-title":"Int J Hyperthermia"},{"key":"4965_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00404-017-4426-5","volume":"296","author":"G-Q Liu","year":"2017","unstructured":"Liu G-Q, Wu J-C, Cao J, Xue Y-P, Dai C-C, Xu J, et al. Comparison of three treatment strategies for cesarean scar pregnancy. Arch Gynecol Obstet. 2017;296:383\u20139.","journal-title":"Arch Gynecol Obstet"},{"key":"4965_CR4","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2020.01.030","volume":"222","author":"R Miller","year":"2020","unstructured":"Miller R, Timor-Tritsch IE, Gyamfi-Bannerman C. Society for Maternal-Fetal Medicine (SMFM) Consult Series #49: Cesarean scar pregnancy. Am J Obstet Gynecol. 2020;222:B2\u201314.","journal-title":"Am J Obstet Gynecol"},{"key":"4965_CR5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/01.AOG.0000218690.24494.ce","volume":"107","author":"MA Rotas","year":"2006","unstructured":"Rotas MA, Haberman S, Levgur M. Cesarean scar ectopic pregnancies: etiology, diagnosis, and management. Obstet Gynecol. 2006;107:1373\u201381.","journal-title":"Obstet Gynecol"},{"key":"4965_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/uog.17568","volume":"51","author":"G Cal\u00ec","year":"2018","unstructured":"Cal\u00ec G, Timor-Tritsch IE, Palacios-Jaraquemada J, Monteaugudoet A, Buca D, Forlani F, et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51:169\u201375.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4965_CR7","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.1111\/ajo.13250","volume":"60","author":"Z-B Ouyang","year":"2020","unstructured":"Ouyang Z-B, Wei S-Y, Zhong B-T. Caesarean scar pregnancy: Look at a leopard through a tube. Aust N Z J Obstet Gynaecol. 2020;60:E53.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"4965_CR8","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/GCO.0000000000000023","volume":"25","author":"K Litwicka","year":"2013","unstructured":"Litwicka K, Greco E. Caesarean scar pregnancy: a review of management options. Curr Opin Obstet Gynecol. 2013;25:456\u201361.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"4965_CR9","first-page":"804","volume":"94","author":"S Marcus","year":"1999","unstructured":"Marcus S, Cheng E, Goff B. Extrauterine pregnancy resulting from early uterine rupture. Obstet Gynecol. 1999;94:804\u20135.","journal-title":"Obstet Gynecol"},{"key":"4965_CR10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1097\/AOG.0000000000002940","volume":"132","author":"O Grechukhina","year":"2018","unstructured":"Grechukhina O, Deshmukh U, Fan L, Kohari K, Abdel-Razeq S, Bahtiyar MO, et al. Cesarean Scar Pregnancy, Incidence, and Recurrence: Five-Year Experience at a Single Tertiary Care Referral Center. Obstet Gynecol. 2018;132:1285\u201395.","journal-title":"Obstet Gynecol"},{"key":"4965_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1046\/j.1469-0705.2000.00300-2.x","volume":"16","author":"Y Vial","year":"2000","unstructured":"Vial Y, Petignat P, Hohlfeld P. Pregnancy in a cesarean scar. Ultrasound Obstet Gynecol. 2000;16:592\u20133.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4965_CR12","first-page":"568","volume":"51","author":"L Jin","year":"2016","unstructured":"Jin L, Chen W, Zhou Y. Expert consensus on diagnosis and treatment of uterine scar pregnancy after cesarean section. Chin J Obstetrics Gynecol. 2016;51:568\u201372.","journal-title":"Chin J Obstetrics Gynecol"},{"key":"4965_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jmig.2017.05.019","volume":"24","author":"S Maheux-Lacroix","year":"2017","unstructured":"Maheux-Lacroix S, Li F, Bujold E, Nesbitt-Hawes E, Deans R, Abbott J. Cesarean Scar Pregnancies: A Systematic Review of Treatment Options. J Minim Invasive Gynecol. 2017;24:915\u201325.","journal-title":"J Minim Invasive Gynecol"},{"key":"4965_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3109\/02656736.2015.1104733","volume":"32","author":"X-G Zhu","year":"2016","unstructured":"Zhu X-G, Deng X-L, Xiao S-S, Wan Y-J, Xue M. A comparison of high-intensity focused ultrasound and uterine artery embolisation for the management of caesarean scar pregnancy. Int J Hyperthermia. 2016;32:144\u201350.","journal-title":"Int J Hyperthermia"},{"key":"4965_CR15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.tjog.2021.03.011","volume":"60","author":"T Mitsui","year":"2021","unstructured":"Mitsui T, Mishima S, Ohira A, Tani K, Maki J, Eto E, et al. hCG values and gestational sac size as indicators of successful systemic methotrexate treatment in cesarean scar pregnancy. Taiwan J Obstet Gynecol. 2021;60:454\u20137.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"4965_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jog.14248","volume":"46","author":"N-C Tsai","year":"2020","unstructured":"Tsai N-C, Cheng L-Y, Yang T-H, Hsu T-Y, Kung F-T. Serum \u03b2-human chorionic gonadotropin profile and its correlations with ultrasound parameters in low-lying-implantation ectopic pregnancy in the first trimester. J Obstet Gynaecol Res. 2020;46:844\u201350.","journal-title":"J Obstet Gynaecol Res"},{"key":"4965_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5603\/GP.2020.0026","volume":"91","author":"F-Y Jiang","year":"2020","unstructured":"Jiang F-Y, Nong W-Z, Su H-Q, Yu S-C, et al. Intrauterine ectopic pregnancy - ultrasound typing and treatment. Ginekol Pol. 2020;91:111\u20136.","journal-title":"Ginekol Pol"},{"key":"4965_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tjog.2015.03.009","volume":"55","author":"M Kanat-Pektas","year":"2016","unstructured":"Kanat-Pektas M, Bodur S, Dundar O, Bak\u0131r VL. Systematic review: What is the best first-line approach for cesarean section ectopic pregnancy? Taiwan J Obstet Gynecol. 2016;55:263\u20139.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"4965_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/uog.1843","volume":"25","author":"J Hasegawa","year":"2005","unstructured":"Hasegawa J, Ichizuka K, Matsuoka R, Otsuki K, Sekizawa A, Okaiet T. Limitations of conservative treatment for repeat Cesarean scar pregnancy. Ultrasound Obstet Gynecol. 2005;25:310\u20131.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4965_CR20","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/humrep\/dem078","volume":"22","author":"J Ben Nagi","year":"2007","unstructured":"Ben Nagi J, Helmy S, Ofili-Yebovi D, Yazbek J, Sawyer E, Jurkovic D. Reproductive outcomes of women with a previous history of Caesarean scar ectopic pregnancies. Hum Reprod. 2007;22:2012\u20135.","journal-title":"Hum Reprod"},{"key":"4965_CR21","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.tjog.2016.07.005","volume":"55","author":"Z-B OuYang","year":"2016","unstructured":"OuYang Z-B, Li H-W, Quan S. The first-line approach for cesarean scar pregnancy: The most adopted being not the best. Taiwan J Obstet Gynecol. 2016;55:761\u20132.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"4965_CR22","doi-asserted-by":"publisher","first-page":"e9584","DOI":"10.1097\/MD.0000000000009584","volume":"97","author":"G-S Cao","year":"2018","unstructured":"Cao G-S, Liu R-Q, Liu Y-Y, Liu J-W, Li L-P, Zhang Q, et al. Menstruation recovery in scar pregnancy patients undergoing UAE and curettage and its influencing factors. Medicine (Baltimore). 2018;97:e9584.","journal-title":"Medicine (Baltimore)"},{"key":"4965_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/humrep\/det459","volume":"29","author":"A Torre","year":"2014","unstructured":"Torre A, Paillusson B, Fain V, Labauge P, Pelage JP, Fauconnier A. Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms. Hum Reprod. 2014;29:490\u2013501.","journal-title":"Hum Reprod"},{"key":"4965_CR24","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.fertnstert.2021.06.015","volume":"116","author":"Q Tang","year":"2021","unstructured":"Tang Q, Qin Y, Zhou Q, Tang J-Y, Zhou Q, Qiao J, et al. Hysteroscopic treatment and reproductive outcomes in cesarean scar pregnancy: experience at a single institution. Fertil Steril. 2021;116:1559\u201366.","journal-title":"Fertil Steril"},{"key":"4965_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.fertnstert.2014.04.003","volume":"102","author":"Z-D Qian","year":"2014","unstructured":"Qian Z-D, Guo Q-Y, Huang L-L. Identifying risk factors for recurrent cesarean scar pregnancy: a case-control study. Fertil Steril. 2014;102:129-134.e1.","journal-title":"Fertil Steril"},{"key":"4965_CR26","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s00404-020-05906-7","volume":"303","author":"X-F Xu","year":"2021","unstructured":"Xu X-F, Li D-D, Yang L, Jing X-J, Kong X-Y, Chen D-Z, et al. Surgical outcomes of cesarean scar pregnancy: an 8-year experience at a single institution. Arch Gynecol Obstet. 2021;303:1223\u201333.","journal-title":"Arch Gynecol Obstet"},{"key":"4965_CR27","doi-asserted-by":"publisher","first-page":"659647","DOI":"10.3389\/fendo.2021.659647","volume":"12","author":"X-Y Sun","year":"2021","unstructured":"Sun X-Y, Liu Y, Tang Y-H, Yu H-Y, Zhao M, Chen Q. Subsequent Fertility in Women Treated for Caesarean Scar Pregnancy With Hysteroscopy: A 5-Year Follow-Up Descriptive Study in a Tertiary Hospital. Front Endocrinol (Lausanne). 2021;12:659647.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04965-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-04965-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04965-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T10:03:35Z","timestamp":1660644215000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-04965-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4965"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-04965-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of Shengjing Hospital of China Medical University. Institutional Review Board of Shengjing Hospital of China Medical University has waived the need of informed consent. And all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"644"}}